Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 26,189 | 78,992 | 73,180 | 70,762 | 42,009 |
| Depreciation Amortization | 901 | 2,883 | 2,086 | 1,302 | 600 |
| Income taxes - deferred | 382 | 11,028 | 11,076 | 11,864 | 11,487 |
| Accounts receivable | -2,580 | -13,565 | -10,000 | -5,357 | -74,902 |
| Accounts payable and accrued liabilities | 149 | -543 | -332 | 488 | -1,296 |
| Other Working Capital | 685 | -16,830 | -7,292 | 10,562 | -58,471 |
| Other Operating Activity | 4,267 | 14,708 | 10,330 | 3,630 | 74,963 |
| Operating Cash Flow | $29,993 | $76,673 | $79,048 | $93,251 | $-5,610 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,197 | -2,336 | -756 | -356 | -256 |
| Purchase Of Investment | -34,622 | -196,304 | -155,583 | -135,832 | -8,153 |
| Sale Of Investment | 31,187 | 110,617 | 64,227 | 35,902 | 15,436 |
| Other Investing Activity | 0 | -163 | -172 | -172 | 0 |
| Investing Cash Flow | $-5,632 | $-88,186 | $-92,284 | $-100,458 | $7,027 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -16 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 162 | 726 | 564 | 340 | 95 |
| Other Financing Activity | 0 | 1,814 | 1,817 | 1,919 | 1,919 |
| Financing Cash Flow | $146 | $2,540 | $2,381 | $2,259 | $2,014 |
| Beginning Cash Position | 21,726 | 30,699 | 30,699 | 30,699 | 30,699 |
| End Cash Position | 46,233 | 21,726 | 19,844 | 25,751 | 34,130 |
| Net Cash Flow | $24,507 | $-8,973 | $-10,855 | $-4,948 | $3,431 |
| Free Cash Flow | |||||
| Operating Cash Flow | 29,993 | 76,673 | 79,048 | 93,251 | -5,610 |
| Capital Expenditure | -2,197 | -2,336 | -756 | -356 | -256 |
| Free Cash Flow | 27,796 | 74,337 | 78,292 | 92,895 | -5,866 |